Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 4
1967 1
1969 3
1970 2
1971 1
1972 1
1973 2
1974 3
1976 4
1977 2
1978 6
1979 4
1980 4
1981 4
1982 4
1983 5
1984 6
1985 2
1986 5
1987 8
1988 7
1989 6
1990 3
1991 10
1992 11
1993 16
1994 8
1995 19
1996 12
1997 8
1998 13
1999 8
2000 5
2001 13
2002 12
2003 12
2004 12
2005 11
2006 7
2007 16
2008 19
2009 19
2010 31
2011 17
2012 22
2013 32
2014 23
2015 26
2016 25
2017 31
2018 37
2019 36
2020 43
2021 54
2022 62
2023 47
2024 59
2025 44

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

818 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial.
Khan AA, Rubin MR, Schwarz P, Vokes T, Shoback DM, Gagnon C, Palermo A, Marcocci C, Clarke BL, Abbott LG, Hofbauer LC, Kohlmeier L, Pihl S, An X, Eng WF, Smith AR, Ukena J, Sibley CT, Shu AD, Rejnmark L. Khan AA, et al. Among authors: gagnon c. J Bone Miner Res. 2023 Jan;38(1):14-25. doi: 10.1002/jbmr.4726. Epub 2022 Nov 12. J Bone Miner Res. 2023. PMID: 36271471 Free PMC article. Clinical Trial.
Efficacy and Safety of TransCon PTH in Adults With Hypoparathyroidism: 52-Week Results From the Phase 3 PaTHway Trial.
Clarke BL, Khan AA, Rubin MR, Schwarz P, Vokes T, Shoback DM, Gagnon C, Palermo A, Abbott LG, Hofbauer LC, Kohlmeier L, Cetani F, Pihl S, An X, Smith AR, Lai B, Ukena J, Sibley CT, Shu AD, Rejnmark L. Clarke BL, et al. Among authors: gagnon c. J Clin Endocrinol Metab. 2025 Mar 17;110(4):951-960. doi: 10.1210/clinem/dgae693. J Clin Endocrinol Metab. 2025. PMID: 39376010 Free PMC article. Clinical Trial.
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial.
Rejnmark L, Gosmanova EO, Khan AA, Makita N, Imanishi Y, Takeuchi Y, Sprague S, Shoback DM, Kohlmeier L, Rubin MR, Palermo A, Schwarz P, Gagnon C, Tsourdi E, Zhao C, Makara MA, Ominsky MS, Lai B, Ukena J, Sibley CT, Shu AD. Rejnmark L, et al. Among authors: gagnon c. Adv Ther. 2024 Jun;41(6):2500-2518. doi: 10.1007/s12325-024-02843-8. Epub 2024 Apr 30. Adv Ther. 2024. PMID: 38691316 Free PMC article. Clinical Trial.
Cardiopulmonary Rehabilitation in Long-COVID-19 Patients with Persistent Breathlessness and Fatigue: The COVID-Rehab Study.
Besnier F, Bérubé B, Malo J, Gagnon C, Grégoire CA, Juneau M, Simard F, L'Allier P, Nigam A, Iglésies-Grau J, Vincent T, Talamonti D, Dupuy EG, Mohammadi H, Gayda M, Bherer L. Besnier F, et al. Among authors: gagnon c. Int J Environ Res Public Health. 2022 Mar 31;19(7):4133. doi: 10.3390/ijerph19074133. Int J Environ Res Public Health. 2022. PMID: 35409815 Free PMC article. Clinical Trial.
Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta-analysis.
Giustina A, di Filippo L, Facciorusso A, Adler RA, Binkley N, Bollerslev J, Bouillon R, Casanueva FF, Cavestro GM, Chakhtoura M, Conte C, Donini LM, Ebeling PR, Fassio A, Frara S, Gagnon C, Latella G, Marcocci C, Mechanick JI, Minisola S, Rizzoli R, Santini F, Shaker JL, Sempos C, Ulivieri FM, Virtanen JK, Napoli N, Schafer AL, Bilezikian JP. Giustina A, et al. Among authors: gagnon c. Rev Endocr Metab Disord. 2023 Dec;24(6):1011-1029. doi: 10.1007/s11154-023-09831-3. Epub 2023 Sep 4. Rev Endocr Metab Disord. 2023. PMID: 37665480 Free PMC article.
X-Linked Hypophosphatemia Management in Children: An International Working Group Clinical Practice Guideline.
Ali DS, Carpenter TO, Imel EA, Ward LM, Appelman-Dijkstra NM, Chaussain C, Jan de Beur SM, Florenzano P, Abu Alrob H, Aldabagh R, Alexander RT, Alsarraf F, Beck-Nielsen SS, Biosse-Duplan M, Crowley RK, Dandurand K, Filler G, Friedlander L, Fukumoto S, Gagnon C, Goodyer P, Grasemann C, Grimbly C, Hussein S, Javaid MK, Khan S, Khan A, Lehman A, Lems WF, Lewiecki EM, McDonnell C, Mirza RD, Morgante E, Morrison A, Portale AA, Rao C, Rhee Y, Rush ET, Siggelkow H, Tetradis S, Tosi L, Guyatt G, Brandi ML, Khan AA. Ali DS, et al. Among authors: gagnon c. J Clin Endocrinol Metab. 2025 Jun 17;110(7):2055-2070. doi: 10.1210/clinem/dgaf093. J Clin Endocrinol Metab. 2025. PMID: 39960858 Free PMC article.
Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial.
Agrinier AL, Morissette A, Daoust L, Gignac T, Marois J, Varin TV, Pilon G, Larose É, Gagnon C, Desjardins Y, Anhê FF, Carreau AM, Vohl MC, Marette A. Agrinier AL, et al. Among authors: gagnon c. Cell Rep Med. 2024 Aug 20;5(8):101682. doi: 10.1016/j.xcrm.2024.101682. Cell Rep Med. 2024. PMID: 39168095 Free PMC article. Clinical Trial.
Gut substrate trap of D-lactate from microbiota improves blood glucose and fatty liver disease in obese mice.
Fang H, Anhê FF, Zada DK, Barra NG, E-Lacerda RR, McAlpin BT, Wylie R, Berthiaume L, Audet-Walsh É, O'Dwyer C, Ghorbani P, Fullerton MD, Gagnon C, Tchernof A, Marette A, Schertzer JD. Fang H, et al. Among authors: gagnon c. Cell Metab. 2025 Sep 2;37(9):1806-1819.e7. doi: 10.1016/j.cmet.2025.07.001. Epub 2025 Jul 29. Cell Metab. 2025. PMID: 40738110 Free article.
818 results